Secukinumab may be remedy for systemic amyloidosis findings secondary to hidradenitis suppurativa.

Tas-Aygar, Gamze; Gonul, Muzeyyen; Ozcan, Ibrahim; Ayli, Mehmet Deniz; Ertoy-Baydar, Dilek

Tas-Aygar, Gamze; Gonul, Muzeyyen; Ozcan, Ibrahim; Ayli, Mehmet Deniz; Ertoy-Baydar, Dilek.

Afiliação

Tas-Aygar G; University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Dermatology Clinic, Ankara, Turkey.
Gonul M; University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Dermatology Clinic, Ankara, Turkey.
Ozcan I; University of Health Sciences, Dr. Sami Ulus Obstetrics and Gynecology, Pediatric Health and Disease Training and Research Hospital, Ankara, Turkey.
Ayli MD; University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Nephrology Clinic, Ankara, Turkey.
Ertoy-Baydar D; Koc University, Pathology Clinic, Istanbul, Turkey.

Dermatol Ther ; 33(6): e14205, 2020 11.

Article em En | MEDLINE | ID: mdl-32829493

Assuntos

Amiloidose; Hidradenite Supurativa; Amiloidose/diagnóstico; Amiloidose/tratamento farmacológico; Amiloidose/etiologia; Anticorpos Monoclonais Humanizados; Hidradenite Supurativa/complicações; Hidradenite Supurativa/diagnóstico; Hidradenite Supurativa/tratamento farmacológico; Humanos; Qualidade de Vida

Palavras-chave

amyloidosis; hidradenitis suppurativa; secukinumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hidradenite Supurativa / Amiloidose Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google